Company intelligence / Profile preview

Shanghai Hile Bio-Technology

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Shanghai Hile Bio-Technology is a Shanghai-based, publicly listed animal health biotech that researches, develops, manufactures and sells a broad portfolio of commercial veterinary biologic vaccines for livestock and poultry (notably hog and poultry), including multiple inactivated and live vaccines for swine fever, streptococcus suis, Newcastle disease, avian influenza, infectious bronchitis, and related combination products across the Chinese market.

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologic
Industry: Veterinary

Partnerships

Joint venture in China with Biogénse Bagó S.A. (Argentina) to expand animal vaccine capabilities and build an international sales network.

Beyond the preview

Go deeper on Shanghai Hile Bio-Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Hile Bio-Technology.

Explore the full profile